World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
70041
World Ranking
1977
National Ranking
1121

Michael L. Blute publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael L. Blute sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 709 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael L. Blute D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael L. Blute sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael L. Blute is affiliated with Harvard University in the United States. Their research primarily centers on medicine, with a notable focus on pulmonary and respiratory medicine, surgery, oncology, molecular biology, and urology.

Their main research topics include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Urological Disorders and Treatments
  • Urologic and reproductive health conditions

Frequent co-authors collaborating with Michael L. Blute include:

  • Douglas M. Dahl
  • Adam S. Feldman
  • Andrew Gusev
  • Matthew Wszolek
  • Chin-Lee Wu

They have published multiple papers in a range of venues, with several appearing repeatedly in specific journals. Common publication venues are:

  • The Journal of Urology (6 publications)
  • Urologic Oncology Seminars and Original Investigations (4 publications)
  • Urologic Clinics of North America (3 publications)
  • Oncogene (2 publications)
  • Asian Journal of Urology (2 publications)

Recent published papers by Michael L. Blute include:

  • "Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus", 2023, Urologic Clinics of North America
  • "Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy", 2021, The Journal of Urology
  • "Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing", 2020, Oncogene
  • "Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification", 2021, Urologic Oncology Seminars and Original Investigations
  • "Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis", 2020, Cancer Medicine

Best Publications

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Guideline for management of the clinical T1 renal mass.

    Steven C Campbell;Andrew C Novick;Arie S. Belldegrun;Michael L Blute

  • Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.

    Inderbir S. Gill;Louis R. Kavoussi;Brian R. Lane;Michael L. Blute

  • Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

    John C. Cheville;Christine M. Lohse;Horst Zincke;Amy L. Weaver

  • Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

    W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton

  • An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.

    Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size

    Igor Frank;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

    Lieping Chen;Scott E. Strome;Eugene D. Kwon

  • Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

    R. Houston Thompson;Susan M. Kuntz;Bradley C. Leibovich;Haidong Dong

  • Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

    Wko Lau;ML Blute;AL Weaver;VE Torres

  • Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

    Horst Zincke;Joseph E. Oesterling;Michael L. Blute;Erik J. Bergstralh

  • Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;M B S Christine Lohse

  • Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy

    R. Houston Thompson;Brian R. Lane;Christine M. Lohse;Bradley C. Leibovich

  • Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy

    R. Houston Thompson;Stephen A. Boorjian;Christine M. Lohse;Bradley C. Leibovich

  • Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy

    Bradley C. Leibovich;Michael L. Blute;John C. Cheville;Christine M. Lohse

  • The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

    Michael L. Blute;Bradley C. Leibovich;Christine M. Lohse;John C. Cheville

  • PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma

    R. Houston Thompson;Haidong Dong;Christine M. Lohse;Bradley C. Leibovich

  • Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome

    John F. Ward;Jeffrey M. Slezak;Michael L. Blute;Erik J. Bergstralh

  • Evidence for a prostate cancer susceptibility locus on the X chromosome.

    Jianfeng Xu;Deborah Meyers;Diha Freije;Sarah Isaacs

  • Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery

    Seth E. Lerner;Craig A. Hawkins;Michael L. Blute;Andreas Grabner

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA can open doors to a wide range of online healthcare degrees and flexible career options. Many students begin with alternative pathways before committing to medical school. For example, those who start as registered nurses might benefit from asn to np programs that help bridge the gap toward becoming a nurse practitioner.

Interest in preventative care also continues to rise. If you're passionate about diet and wellness, online nutrition degrees provide a solid foundation for a career in nutritional science or dietetics.

For those focused on leadership or hospital management, it's essential to choose programs with strong credentials. Look for cahme accredited online MHA programs to ensure high academic standards and employer recognition.

Finally, working nurses seeking to advance without onsite requirements can opt for online rn to bsn programs without clinicals. These flexible options allow for continued employment while furthering education. Each of these pathways helps diversify your healthcare career opportunities.

Best Scientists Citing Michael L. Blute

Trending Scientists

Recently Published Articles